Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA(1c), weight and hypoglycaemic event incidence

por McEwan, P., Bennett, H., Bolin, K., Evans, M., Bergenheim, K.
Publicado 2018

Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective

por Charokopou, M., McEwan, P., Lister, S., Callan, L., Bergenheim, K., Tolley, K., Postema, R., Townsend, R., Roudaut, M.
Publicado 2015

HSD27 Constrained Optimization Model to Estimate Best Booster Allocation Strategy to Minimize Hospital Bed-Days Under a Fixed Healthcare Budget

por Kapoor, R, Standaert, B, Nolan, T, Pezalla, EJ, Arnetorp, S, Bergenheim, K, Bungey, G, Darroch-Thompson, D, Gani, R, Meeraus, W, Okumura, L, Sutton, K, Tichy, E, Yokota, R, Demarteau, N
Publicado 2022